<DOC>
	<DOCNO>NCT01071993</DOCNO>
	<brief_summary>To determine statin therapy plus intravenous normal saline , patient chronic renal insufficiency undergo angiography , superior placebo plus intravenous normal saline therapy prevention CIN .</brief_summary>
	<brief_title>Efficacy Statins In Prevention CIN</brief_title>
	<detailed_description>Due conflict available data , practice guideline establish order prevent contrast-induced nephropathy ( CIN ) . Our goal determine statin therapy plus intravenous normal saline , patient chronic renal insufficiency undergo angiography , superior placebo plus intravenous normal saline therapy prevention CIN .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>1 . Adults &gt; 18 year age undergoing coronary peripheral angiography without intervention Cr &gt; 1.3 mg/dL GFR &lt; 60 mL/min 2. endstage renal disease dialysis acute renal failure previous iodinate contrast medium exposure within 7 day study entry history hypersensitivity statins pregnancy lactation emergent coronary angiography , ST elevation myocardial infarction ( STEMI ) , cardiogenic shock prisoner patient already maximum dose statin patient receive Nacetylcysteine sodium bicarbonate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>prevention</keyword>
	<keyword>nephropathy</keyword>
</DOC>